Dr. Kurokawa has over 40 years of medical and pharmaceutical experience in the U.S. and Japan. Dr. Kurokawa is one of the most well-known and influential experts in the Japanese pharmaceutical industry today. He has held multiple high level positions including: Advisor to the Cabinet of Japan, Chair of Special Committee for Drug Evaluation of MHLW (Ministry of Health, Labour, and Welfare, Japan), Chair of MHLW’s Investigation Panel for Anti-cancer and Unapproved Drugs, Chair of National Health Policy of MHLW, Chair of Committee for Drug Approval & Reimbursement, President, Science Council of Japan & Pacific Science Association. He is a Member of the Science and Technology Policy Committee of the Cabinet Office as well as a Professor at UCLA, the University of Tokyo, and the National Graduate Institution for Policy Studies.
Dr. Trygstad has over 30 years of professional experience in the pharmaceutical industry. Most recently he was a Vice President at Quintiles in the Medical and Scientific division specializing in Phase I studies. Prior to that, Dr. Trygstad was a senior consultant at Scripps Clinic and Research Institute and a professor at UCSD medical school. From 1968 to 1979 he held academic positions at Indiana University and UCLA, where he was professor of Pediatrics and Nephrology. Dr. Trygstad has experience in almost all therapeutic areas as either an investigator or as an Executive during his 13 years at Quintiles. Dr. Trygstad received his MD degree with honors from the University of Florida and is board certified in Pediatrics, Internal Medicine and Nephrology.